european manufacturer, page-21

misterS - I do not take offence at your thoughts.

Regarding your concerns about my posting:

1. The short-selling point I made was based on the experience of friends who sadly buckled when DNDN's sp plunged due to what could have been a coordinated attack by short-sellers - the take away message here is if you believe in the stock then don't let go of it.

2. Yes, I strongly believe that the listing has been factored into the share price because, as I said, if the listing does not go ahead I believe the share price will plunge - do you think it would be unchanged in such a scenario? Why do I need to list the (numerous) reasons why the listing will, 99.999% likely, go ahead? The regular readers (who are presumably long term share holders as I am) are well aware of them. To be honest I cannot think of one reason why the listing will not go ahead but, I said before, I will rest a lot easier when I see the formal announcement - I know I am not alone in that respect. What happens to the share price when PRR is actually available for trade on the Nasdaq is anyone's guess - it is very likely to climb dramatically - but I don't have next month's Wall Street journal. I am sure there are some investors who are well aware of PRR's potential but who are waiting for the listing or the formal announcement before buying.

3. Regarding the Fraunhofer Institute - perhaps you are right - perhaps all they do is manufacture the vaccine but looking at the Institute's profile it seems to me they have a lot more to offer in terms of their expertise than just a manufacturing plant. Perhaps other posters could shed some light on this.

All I am doing here is sharing my ideas about PRR. Along the way I know I am going to unintentionally rattle a few cages but if out of that we all learn something new then, IMHO, it's been worthwhile. I strongly believe PRR will do well and I won't sell anytime soon.

ticketmaster - I am a PRR shareholder with a few points of view, nothing else.